There are a few hurdles in your way, but the price may be worth it.
UVA Health researchers are advancing a technology that may allow new vaccines to be designed, tested and distributed in weeks ...
Backed with $82 million and led by two of BioMarin’s former executives, Mendra plans to acquire rare disease assets and use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results